Victoria-Jungfrau Collection AG has been acquired by AEVIS Holding SA
March 2014 — The shareholders of Victoria Jungfrau Collection AG, (VJC) the Swiss group of luxury hotels, received a public takeover offer from AEVIS Holding SA (AEVIS), a Swiss investment group focusing on the healthcare sector, acquiring a majority shareholding for US$69.5 million.
The Victoria-Jungfrau Collection AG is a small but exclusive hotel group with a unique portfolio of luxury five-star hotels of long standing. Other hotels of the group include The Victoria-Jungfrau Grand Hotel & Spa in Interlaken, the Palace Luzern on the shores of Lake Lucerne, the Eden au Lac in Zurich and the renowned Bellevue Palace in Bern.
AEVIS invests in the healthcare, life sciences, services and lifestyle sectors. The firm wishes to progressively develop new sectors of activity, amongst others in the sector of outpatient surgical centers, radiology and dental medicine and hotel or hotel related activities.
Our role in the transaction
Oaklins' team in Switzerland was mandated by the board of VJC to assist in the assessment of the bids from a financial perspective. It was imperative to focus on the interests of the company and the shareholders and to achieve a fair price, while taking into consideration the strategic plans for the target of each bidder. The competitive situation of two bidders resulted in a stepwise increase of the price.
Talk to the deal team
Related deals
Cibus has acquired Aweta from Standard Investment
Standard Investment has reached an agreement with Cibus Capital, advisor to the Cibus funds, on the sale of Aweta, a global leader in fruit and vegetable sorting, grading and packing equipment. Completion of the transaction is expected in the coming weeks. The transaction provides Aweta with a strong partner to support the company’s next growth phase. Under Cibus’ ownership, Aweta will pursue further international growth and accelerate investment in R&D, supporting the installed base and product innovation, including software and AI capabilities. Aweta’s leadership team will continue to lead the business.
Learn moreKatalyst Diagnostics has been acquired by Cruinn Diagnostics
Katalyst Diagnostics Ltd. has been acquired by Cruinn Diagnostics Ltd. The acquisition strengthens Cruinn Diagnostics’ presence in the UK diagnostics market, adding established NHS customer relationships, local commercial infrastructure and a complementary portfolio of point-of-care diagnostic solutions. It also creates opportunities to introduce Cruinn Diagnostics’ products to UK customers while leveraging its established Irish platform to accelerate the growth of Katalyst Diagnostics’ portfolio in Ireland. With more than 100 employees and revenues in excess of US$56 million, the combined business will continue to focus on the UK market, where Cruinn Diagnostics sees significant opportunities to expand through further investment and targeted M&A.
Learn moreGroGlass has been acquired by Apogee Enterprises
Apogee Enterprises, Inc. (Nasdaq: APOG), a leading US provider of architectural building products, services and high-performance coated materials, has acquired GroGlass, a Latvia-based developer and manufacturer of high-performance anti-reflective and UV-protective glass coatings. The acquisition brings GroGlass’ differentiated coating technologies and materials science expertise into Apogee’s performance surfaces segment, broadening its product offering and market reach while expanding its manufacturing and R&D presence in Europe.
Learn more